Dr. Jo Kennelly Ph.D

Dr. Jo Kennelly Ph.D is a prominent figure in the global health sector, particularly in the field of HIV vaccine development. She is the Founder and Executive Chair of Malaika Vx, a company focused on developing an HIV vaccine based on natural immunity to the virus.12

Professional Background

Dr. Kennelly is a global health executive with extensive experience in translating scientific research into strategic and business plans. Her expertise lies in making complex scientific concepts approachable and compelling.1 As the leader of Malaika Vx, she is at the forefront of innovative approaches to HIV prevention.

Malaika Vx

Malaika Vx is an HIV vaccine company that Dr. Kennelly founded. The company's unique approach is based on studying natural immunity to HIV, which could potentially lead to breakthrough developments in vaccine technology.23

Contributions to HIV Research

Dr. Kennelly is actively involved in advancing HIV vaccine development through biotechnology. She has authored papers discussing the challenges in supporting and funding HIV vaccine development, demonstrating her commitment to addressing critical issues in this field.4

Career Highlights

Throughout her career, Dr. Kennelly has bridged the gap between science and politics. This unique position has provided her with numerous notable experiences, including discussions with political figures such as former Canadian Prime Minister Brian Mulroney.5

Dr. Jo Kennelly's work at Malaika Vx and her contributions to global health, particularly in HIV vaccine research, position her as a significant figure in the biotechnology and public health sectors.